Jean Bénard

6.4k total citations
150 papers, 4.5k citations indexed

About

Jean Bénard is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jean Bénard has authored 150 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Neurology, 67 papers in Molecular Biology and 57 papers in Oncology. Recurrent topics in Jean Bénard's work include Neuroblastoma Research and Treatments (68 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Jean Bénard is often cited by papers focused on Neuroblastoma Research and Treatments (68 papers), Cancer therapeutics and mechanisms (23 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Jean Bénard collaborates with scholars based in France, United States and Switzerland. Jean Bénard's co-authors include G Riou, Sétha Douc‐Rasy, Ute M. Moll, Michael P. LaQuaglia, Jean‐Charles Ahomadegbe, Olivier Hartmann, Dominique Valteau‐Couanet, Gilda Raguénez, Pierre Duvillard and Étienne Blanc and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jean Bénard

148 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Bénard France 38 2.6k 1.8k 1.4k 973 379 150 4.5k
Meredith S. Irwin Canada 43 4.2k 1.6× 3.1k 1.7× 1.9k 1.3× 1.5k 1.6× 456 1.2× 124 6.7k
Olaf Witt Germany 40 4.6k 1.8× 1.6k 0.9× 1.1k 0.8× 628 0.6× 454 1.2× 163 6.7k
Subrata Sen United States 41 5.5k 2.1× 3.4k 1.9× 472 0.3× 2.2k 2.2× 270 0.7× 111 8.2k
Donald L. Durden United States 38 3.3k 1.3× 1.1k 0.6× 273 0.2× 1.0k 1.0× 247 0.7× 108 5.3k
Volker Ehemann Germany 33 2.3k 0.9× 889 0.5× 413 0.3× 798 0.8× 233 0.6× 96 3.5k
Paul Haluska United States 38 2.5k 1.0× 2.0k 1.1× 214 0.2× 1.1k 1.2× 376 1.0× 114 4.9k
John F. Lyons United States 32 2.7k 1.0× 1.3k 0.8× 214 0.2× 551 0.6× 276 0.7× 81 4.3k
Makoto Saegusa Japan 38 1.8k 0.7× 1.3k 0.8× 199 0.1× 680 0.7× 484 1.3× 163 3.8k
Vita Golubovskaya United States 39 2.3k 0.9× 1.6k 0.9× 253 0.2× 705 0.7× 136 0.4× 93 4.3k
Bjørn Risberg Norway 41 1.8k 0.7× 1.4k 0.8× 152 0.1× 877 0.9× 456 1.2× 131 4.6k

Countries citing papers authored by Jean Bénard

Since Specialization
Citations

This map shows the geographic impact of Jean Bénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Bénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Bénard more than expected).

Fields of papers citing papers by Jean Bénard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Bénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Bénard. The network helps show where Jean Bénard may publish in the future.

Co-authorship network of co-authors of Jean Bénard

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Bénard. A scholar is included among the top collaborators of Jean Bénard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Bénard. Jean Bénard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Cindy S., Marie‐Sophie Noël‐Hudson, Jean Bénard, et al.. (2015). Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding. European Journal of Pharmaceutical Sciences. 76. 18–26. 2 indexed citations
2.
Gattolliat, Charles‐Henry, Frédéric Pendino, Josette Hillion, et al.. (2012). Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant. Molecular Cancer Therapeutics. 11(11). 2384–2393. 13 indexed citations
3.
Puiffe, Marie‐Line, et al.. (2010). p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma. BMC Cancer. 10(1). 473–473. 17 indexed citations
4.
Cabrera, Jorge Rubén, Céline Delloye‐Bourgeois, Gabriel Ichim, et al.. (2010). Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. Journal of Clinical Investigation. 120(3). 850–858. 59 indexed citations
5.
Raguénez, Gilda, et al.. (2009). Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer. 9(1). 97–97. 13 indexed citations
6.
Bénard, Jean, Gilda Raguénez, Audrey Kauffmann, et al.. (2008). MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S. Molecular Oncology. 2(3). 261–271. 50 indexed citations
7.
Chauchereau, Anne, Sylvestre Le Moulec, G. Fromont, et al.. (2007). Establishment of a new human prostate cancer cell line, IGR-CaP1, from a localized epithelial prostate cancer.. Cancer Research. 67. 3880–3880. 1 indexed citations
8.
Olivennes, F., Geri Méduri, Catherine Lhommé, et al.. (2006). Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Human Reproduction. 21(12). 3241–3245. 25 indexed citations
9.
Blanc, Étienne, G. Le Roux, Jean Bénard, & Gilda Raguénez. (2004). Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene. 24(7). 1277–1283. 81 indexed citations
10.
Raguénez, Gilda & Jean Bénard. (2003). Prédire le potentiel métastatique : l’apport de la génomique. médecine/sciences. 19(11). 1050–1051. 1 indexed citations
11.
Thiery, Jérôme, Guillaume Dorothée, Hédi Haddada, et al.. (2003). Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function. The Journal of Immunology. 170(12). 5919–5926. 26 indexed citations
12.
Satgé, Daniel, Annie J. Sasco, Dominique Plantaz, Jean Bénard, & Michel Vekemans. (2001). Abnormal Number of X Chromosomes and Neuroblastic Tumors. ˜The œAmerican journal of pediatric hematology/oncology. 23(5). 331–332. 4 indexed citations
13.
Valent, Alexander, Jean Bénard, Bernard Clausse, et al.. (2001). In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of Micronuclei. American Journal Of Pathology. 158(5). 1579–1584. 61 indexed citations
14.
Raguénez, Gilda, Étienne Blanc, David Goldschneider, et al.. (2001). Vers une carte génétique fonctionnelle des neuroblastomes métastatiques pour une thérapeutique adaptée. Bulletin du Cancer. 88(3). 295–304. 1 indexed citations
15.
Bénard, Jean & J.C. Ahomadegbe. (1997). [TSG101 and breast cancer: a correctly named tumor-suppressor gene?].. PubMed. 84(12). 1141–2. 1 indexed citations
16.
Ortega, Richard, Barbara Gouget, Ph. Moretto, et al.. (1997). Trace metal content in distinct genotypes of human neuroblastoma cells: Preliminary results. Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms. 130(1-4). 449–453. 6 indexed citations
17.
Rubie, H, Olivier Hartmann, Jean Michon, et al.. (1997). N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.. Journal of Clinical Oncology. 15(3). 1171–1182. 148 indexed citations
18.
Vassal, Gilles, Jean Bénard, Jackie Morizet, et al.. (1996). Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. British Journal of Cancer. 74(4). 537–545. 89 indexed citations
19.
Prévost, Grégoire, et al.. (1996). Somatostatin-14 Mainly Binds the Somatostatin Receptor Subtype 2 in Human Neuroblastoma Tumors. Neuroendocrinology. 63(2). 188–197. 17 indexed citations
20.
Fajac, Anne, Jean Bénard, Catherine Lhommé, et al.. (1995). c‐crbB2 gene amplification and protein expression in ovarian epithelial tumors: Evaluation of their respective prognostic significance by multivariate analysis. International Journal of Cancer. 64(2). 146–151. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meredith S. Irwin Breakdown of academic impact, for papers by Olaf Witt Breakdown of academic impact, for papers by Subrata Sen Breakdown of academic impact, for papers by Donald L. Durden Breakdown of academic impact, for papers by Volker Ehemann Breakdown of academic impact, for papers by Paul Haluska Breakdown of academic impact, for papers by John F. Lyons Breakdown of academic impact, for papers by Makoto Saegusa Breakdown of academic impact, for papers by Vita Golubovskaya Breakdown of academic impact, for papers by Bjørn Risberg
Rankless by CCL
2026